pharmaceutics exam 2 according to exam prep. sheet Flashcards

1
Q

hard gelatin capsules

what is it made of

what does it consist of

how is it intended to be used?

what part of hard capsules is soluble in water

what part of hard capsules can be digested and absorbed

what happens when Gelatin is dissolved

how are most gelatins colored?

how is gelatin obtained?

what is the difference between gelatin in air vs when moist?

how much moisture do hard capsules contain?

how is the size of hard capsules determined

sizes of capsules

how many pharmacists compound capsules?

how do pharmacists fill hard capsules?

A
  • used to make most capsules
  • the capsule is made of:
    gelatin, sugar & water
  • they are clear, colorless and tasteless

what it consists of
- has a long base or body with a small diameter
- cap to slide over the base

intended to be
- swallowed whole
- contents should be opened and administered in food or liquid with the acceptance of a pharmacist

  • the gelatin is soluble in hot water & in warm gastric fluids
  • gelatin is digested by proteolytic enzymes and absorbed
  • When gelatin dissolves it exposes its medicinal contents to the gastric (or intestinal) bodily fluids
  • Most are colored with FD&C and D&C dyes and made opaque by adding titanium dioxide.

Gelatin is obtained by the partial hydrolysis of collagen obtained from
- skin,
- white connective tissue, and
- bones of animals

  • While stable in air, gelatin is subject to microbial decomposition when moist
  • Hard capsules: contain between 13-16% moisture, but poor storage conditions can increase this level. Not good!
  • size is determined by how much material will go inside
  • sizes: 000 (largest) to 5 (smallest), 8 actual sizes [000,00,0,1,2,3,4 and 5]
  • A pharmacist may compound capsules of a single medicinal agent, or combination of agents at the precise dosage prescribed for the patient

pharmacists use the punch method to fill capsules:
- Start with the exact number of capsules to be filled
- Powder to be encapsulated and placed on a sheet of paper, clean glass, or porcelain plate
- Using a spatula powder is formed into a cake
- Empty capsule body is held between the thumb and forefinger and “punched” vertically into the powder cake repeatedly until filled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

soft gelatin capsules

how do they look/are they elegant?

what are they prepared to contain? what kind of liquids cannot be in soft capsules?

when should soft capsules not be used?

what preservatives are used to retard microbial growth

A
  • they are pharmaceutically elegant and easily swallowed

Prepared to contain liquid, paste & dry fills
– Liquids that can easily migrate through the capsule shell cannot be encapsulated into soft gelatin capsules– so if the liquid can easily move through the shell, then it cannot be used

When not to be used?:
– When water content is > 5%
– When low molecular weight water-soluble and organic compounds are employed such as
* alcohols, ketones, amines, and esters.

Preservatives such as methylparaben and/or
propylparaben is used to retard microbial growth – these are antifungal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

capsule size

how is the size determine

what are the size ranges for humans

how many sizes are there for capsules

how can pharmacists utilize the sizes?

A
  • the size is always determined by the amount of material to be incorporated
  • For human use: 000 (the largest) to 5 (the smallest) are commercially available.
  • There are 8 actual sizes [000,00,0,1,2,3,4 and 5]
    * Numerical designations are arbitrary, and do not indicate the capsule’s capacity
  • A pharmacist may compound capsules of a single medicinal agent, or combination of agents at the precise dosage prescribed for the patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

preparation & filling

if things are to be added to preparations to facilitate manufacturing, what must be be

what are the two types of ways to fill capsules?

what must you keep in mind when cleaning and polishing capsules?

A

they must be:
– Harmless (in the quantities used)
– Do not exceed the minimum amounts required to provide their intended effect
– Do not impair the bioavailability of the product
– Do not interfere with assays to evaluate dosage form

method 1 to fill capsule: torbial torsion scale
- Formulation must be weighed directly to the capsule. It wouldn’t be accurate otherwise.
- To compensate for the weight of the empty capsule being filled, the same capsule must be placed on the other side of the balance with a weight equal to the amount to be filled

method 2: punch method
Pharmacists use the “punch” method
– Start with the exact number of capsules to be
filled
– Powder to be encapsulated and placed on a sheet of paper, clean glass, or porcelain plate
– Using a spatula powder is formed into a cake
An empty capsule body is held between the thumb and forefinger and “punched” vertically into the powder cake repeatedly until filled.

when cleaning and polishing capsules:
- Small amounts of powder may adhere to the outside of capsules after filling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cleaning & polishing

  • what may adhere on the outside of the capsule

what must you do before packaging and dispensing and how do you do it

for large-scale cleaning, what can remove extraneous materials?

A

Small amounts of powder may adhere to the outside of capsules after filling

  • Must remove before packaging and dispensing, wipe with clean gauze or cloth
  • On large-scale cleaning, a vacuum can remove extraneous materials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

compendial requirements

Things added to preparations to facilitate their manufacture can only be used if?

A

– Harmless (in the quantities used)

– Do not exceed the minimum amounts required to provide their intended effect

– Do not impair the bioavailability of the product

– Do not interfere with assays to evaluate dosage form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

inspecting, counting, storage, and handling

are capsules or tablets easier to store and transport

A

inspecting

counting:

handling:

capsules are Easier storage and transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

influences of food on gastric emptying

for light and heavy objects, do they float or sink

A
  • the more food in your stomach, the longer it takes for gastric emptying to occur and for the capsule to be absorbed

light objects float on gastric contents

heavy objects fall to the base of greater curvature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

different types of tablets

are tablets all the same size

why are there smooth tablets
C
M
S
F
G
E
B
I
E
V

A
  • Often vary in size,
    shape, hardness, thickness, and in their ability to dissolve In fluids.
  • These tablets are grooved
    - Are therefore intended
    to be broken into two parts.
    - Why? Offers flexibility
  • Patients can swallow
    them easily or use in divided
    doses

Compressed tablets (C.T.):
Usually contain the following in addition to medicinal agents
* Diluents or Fillers: Add bulk to prepare a certain size
* Binder or Adhesives: Promote adhesion of the particles
of the formulation
* Disintegrants: Promotes breakup of tablets/drug availability
* Antiadherents/ glidants/ or lubricating agents
* Miscellaneous Adjuncts: Colorants and flavorants to
enhance overall appearance

  • Multiple compressed tablets (M.C.T.):
    More than a single compression
  • Produces multiple-layered tablet or a tablet within a tablet
  • Each layer may contain diff. medicinal agents. Why? * Separation may be required to avoid chemical and
    physical incompatibility
  • Staged drug release
  • General appearance of multiple-layered tablet
  • Sugar-coated tablets (S.C.T):
    Compressed tablet can be covered with a colored or an uncolored sugar layer
    – The coating is water soluble
    – The coating is quickly dissolved after swallowing
    – The coating protects the enclosed drug from the environment
    – The coating enhances the general appearance of tablets and permits imprinting of identifying manufacturer’s info.
    – Disadvantages to sugarcoating tablets are,
    – the time and expertise required in the coating process,
    – the increase in size, weight, and shipping costs. * May be 50% larger and heavier than uncoated tablets
  • Film-coated tablets (F.C.T.):
    These compressed tablets are coated with a thin layer of a polymer capable of forming a skin-like film over the tablet
  • Usually colored
  • More durable, less bulky, and less time-consuming to apply than sugar-coatings.
  • Designed to rupture and expose the core tablet at the desired location within the gastrointestinal tract
  • Gelatin-coated tablets:
    GElCAP,
    – Capsule-shaped compressed tablets
    – Facilitates swallowing and compared to unsealed capsules, gelatin tablets are more tamper-evident
  • Enteric-coated tablets (E.C.T.):
    Have delayed release characteristics
  • Designed to pass unchanged through stomach intestines where the tablets disintegrate and allow drug dissolution.
  • Mainly used when by-passing
    the stomach to improve drug absorption
  • Buccal or sublingual tablets:
    These are flat, oval tablets intended to be dissolved in the buccal pouch, or beneath the tongue through absorption through the oral mucosa
    – An alternative for drugs that are poorly absorbed from the G.I. Tract
    – Buccal tablets designed to erode slowly
    – Sublingual tablets designed to provide rapid release
    Buccal: In direction of the cheek Sublingual: Below or beneath the tongue
    The dosage form must remain in place
  • Total area of absorption is low compared to
    other routes- 100 to 170 cm2
    – Taste must be bland, or not acceptable for use – must also be a non-irritant
    – Drug should not discolor or erode teethLining of the epithelium is keratinized for buccal and
    sublingual, but the epithelium for sublingual is thinner.
  • What does this tell us about drug absorption?

chewable:
Have a creamy base usually of specially flavored and colored mannitol
* Rapid disintegration when chewed or allowed to dissolve in mouth
* Ideally suited for children and adults who have difficulty swallowing solid dosage forms.

molded tablets
ablet triturates (TT) may be prepared by compression and by molding.
* In terms of appearance very soft and soluble
* Diluent: Lactose and Sucrose usually
* Designed for rapid dissolution
* Pharmacists may insert TT inside a capsule or
dissolved in liquids to provide accurate amounts
of potent drugs.

Instant Disintegrating/ Dissolving tablets * Extended Release Tablets (E.R.)

  • Vaginal Tablets:
    Also called vaginal inserts
  • Uncoated and bullet or ovoid shaped tablets * Inserted in vagina for localized effects
    – Antibacterials for the treatment of Vaginitis caused by Hemophilus vaginalis or
    – Antifungal for treatment of vulvo vaginitis candidiasis caused by Candida albicans and related species
    42
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

quality standards

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

dissolution

which tablet is designed for rapid dissolution

A

molded tablet (M: T)
* Designed for rapid dissolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

wet granulation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

packaging and storage

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

dry granulation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

lozenges

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

lollipops

A
17
Q

Modified-Release Delivery Systems
Terminology- General types

A
18
Q

Packaging and storage requirements

A
19
Q

Candidates for extended release products

A
20
Q

Factors affecting percutaneous absorption

A
  • intracellular matrix is relatively polar in nature.
  • Intercellular lipids are lipophilic.
  • Permeation requires repeated partitioning between the polar environment and the lipophilic domain.

For the intercellular route
- Provide the only continuous route through the stratum corneum.

  • The polar pathway is the diffusion of rate limiting region of very polar permeant.
  • Less polar permeant through the lipid pathway

simple passive diffusion across SC: Vehicle, SC, epidermis, dermis

  • size affects it as well:
21
Q

Iontophoresis

A
  • a method used to enhance permeability
  • mechanisms: electrophoresis, electro-osmosis, increased permeability

how it works:
- put a patch on, this patch is a battery with a + and - end
- an electric current is passed from the positive side to the negative side of the patch battery
- the ionized drug comes from the positive side and follows the current but gets dropped off into the bloodstream.
- the counter ion (which is negative) moves to the negative side

22
Q

Chemical enhancers

A
  • one of the disadvantages of TDD because Contact allergic dermatitis (involves host immunological activity)
    – Contact irritant dermatitis (direct toxic injury to cell membranes, cytoplasm, or nuclei)
  • helps with permeation
  • Pharmacologically inert
  • Non-toxic, non-irritating, non-allergenic
  • Reliable and predictable
  • Immediate recovery of the skin
    (reversible disruption of the skin)
  • Compatible with the API

examples:
- Lipophilic solvents
Dimethylsulfoxide (DMSO)
Dimethylformamide (DMF)
2-Pyrrvolidinone

  • Surface active agents
    Sodium lauryl sulfate (SDS)
    Dodecyl methyl sulfoxide
  • Two-component system
    Propylene glycol-oleic acid
    1,4 butane diol-linoleic acid
  • they strip lipids off of the stratum corneum therefore allowing drugs to go through
  • ethanol
  • glyceryl monoethyl ether
  • monoglycerides
  • isopropyl myristate
  • lauryl alcohol (aka lauric acid, lauryl lactate)
  • terpinol
  • menthol
  • D-limonene
  • beta-cyclodextrin
  • DMSO
  • Polysorbates
  • fatty acids
  • bile salts
  • N-methylpyrrolidone
  • polyglycosylated glycerides
  • 1-dodecylaza cyclohexane-2-one
  • cyclopentadecalactone
  • akyl-2-alkanoate ester
  • 2-(n-nonyl)-1,3-dioxolane

Water As An Enhancer
- Hydration causes corneocyte swelling and keratin bundle dissociation

Mechanisms for Chemical Enhancers
- increase the partition of the drug into the stratum corneum.

  • disrupt the highly ordered structure of the intercellular lipids.
  • interact with intracellular proteins embedded in the corneocytes to increase the transcellular permeation.
23
Q

Sonophoresis

A
  • Ultrasonic refers to sound waves whose frequency is >20 KHz
  • the movement of drugs through living skin and into soft tissue under the influence of an ultrasonic perturbation
  • you have a power supply attached to an ultrasonic transducer attached to the skin and the applied formulation sends sound waves through the skin to allow chemicals to pass through the skin
24
Q

Monolithic systems

A

is a type pf TDD

has a backing with a rate-controlling matrix containing drug then the adhesive

25
Q

Examples of TDDSs on the market

A

Iontophoresis Products:
- E-Trans Fentanyl Patch (Alza, 2004).
- Indication: post-operation pain or cancer chronic pain.
- Patient self-controllable.

Estradiol
A natural hormone used for the relief of post- menopausal syndromes and osteoporosis.
st
* Oral dosed undergoes significant 1 pass
* Short half-life = 1 hr
* Not substantially metabolized by skin
* Convenient once to twice a week dosing on the trunk (abdomen, buttock)

Vivelle-Dot
Vivelle-Dot® contains estradiol in a multipolymeric adhesive. The system is designed to release estradiol continuously upon application to intact skin.
1. A translucent polyolefin film
2. An adhesive formulation containing estradiol, acrylic adhesive, silicone adhesive, oleyl alcohol, povidone, and dipropylene glycol
3. A polyester release liner.

Transdermal Scopolamine
Antimuscarinic drug, natural ingredient found in belladonna plant used for motion sickness
1st transdermal drug device approved by FDA
Non-irritating
Potent drug: 1 mg/72 hr
Short-half life (2.9 ± 1.2 h), anticholinergic side- effects when given orally

Scopolamine
MW = 303.35, pKa = 7.55-7.81.
* The Transderm Scop® film: 0.2 mm thick and 2.5 cm2 (1) Backing layer of tan-colored, aluminized, polyester film
(2) Drug reservoir: light mineral oil, and polyisobutylene
(3) Rate controlling microporous polypropylene membrane
(4) Adhesive formulation of mineral oil, polyisobutylene, and scopolamine.
(5) A protective peel strip of siliconized polyester, which covers the adhesive layer

Clonidine (Catapres-TTS)
An antihypertensive agent
Oral drug undergoes significant 1st pass
Highly lipid soluble
Low therapeutic concentration (0.2-2 ng/mL)
Once a week
4-layers: backing, reservoir, micro-porous membrane, adhesive formulation

Nitroglycerin
Antianginal drug used for prevention of angina pectoris due to coronary artery disease
A Vasodilator
Very short-half life (min)
Extensive 1st pass
Low dose (Cpss 1.2 – 10 ng/mL)
Tolerance is common for long term use
Side-effects include headache, dizziness, and hypotension, and skin irritation
Transderm-Nitro (Novartis) Nitro-Dur (Key)
Deponit (Schwarz Pharma)

Nicotine Patches
To provide nicotine replacement therapy to obtain plasma levels of nicotine that would prevent or lessen the severity of the withdrawal symptoms

Fentanyl (Duragesic®)
DURAGESIC® (fentanyl transdermal system) is a transdermal system providing continuous systemic delivery of fentanyl, a potent opioid analgesic, for 72 hours.

Fentanyl Patches (mylan)
1. Drug in adhesive Matrix Patch. 2. No rate controlling membrane.

Oxytrol (Oxybutynin) for Overactive Bladder
Layer 1 (Backing Film) is a thin flexible polyester/ethylene-vinyl acetate film that provides the matrix system with occlusivity and physical integrity and protects the adhesive/drug layer.
Layer 2 (Adhesive/Drug Layer) is a cast film of acrylic adhesive containing oxybutynin and triacetin.
Layer 3 (Release Liner) is two overlapped siliconized polyester strips that are peeled off and discarded by the patient prior to applying the matrix system.

OXYTROLTM Oxybutynin Transdermal System
OXYTROL is designed to deliver oxybutynin continuously and consistently over a 3- to 4-day interval after application to intact skin. OXYTROL is available as a 39 cm2 system containing 36 mg of oxybutynin. It has a nominal in vivo delivery rate of 3.9 mg oxybutynin per day through skin of average permeability
* Oxybutynin is an antispasmodic, anticholinergic agent.

Lidoderm (Endo Pharm)
Lidoderm (lidocaine patch 5%) is comprised of an adhesive material containing 5% lidocaine, which is applied to a non-woven polyester felt backing and covered with a polyethylene terephthalate (PET) film release liner. The release liner is removed prior to application to the skin. The size of the patch is 10 cm x 14 cm.
* Each adhesive patch contains 700 mg of lidocaine in an aqueous base.
* The Lidoderm® patch is the only topical analgesic indicated to treat the pain of postherpetic neuralgia (PHN).
* 12-hour once-daily dosing up to 3 patches at a time
51

Lidoderm for Postherpetic Neurogalia (PHN)
PHN is the pain after the rash from shingles is gone
 Shingles are caused by chicken- pox infection of nerves
 Pain can last for 6 months
 Zostrix cream
 five-six times a day. It will take two to three weeks of use before the cream will start to work

Ortho-Evra (Ortho-McNeil Pharm)

  • The ORTHO EVRA birth control patch is a highly effective, weekly hormonal birth control patch that is worn on the skin to prevent pregnancy. The patch is worn for one week and replaced on the same day of the week for three consecutive weeks, with the fourth week “patch-free.” ORTHO EVRA combines the efficacy of the birth control pill with once-a-week dosing.
  • ORTHO EVRA contains two types of hormones: estrogen (ethinyl estradiol) and progestin (norelgestromin). Once you apply the Patch to your body, low doses of these hormones are continuously transferred through your skin and into your bloodstream to help prevent pregnancy.
  • ORTHO EVRA can be worn in several discreet locations: buttock, abdomen, upper torso, or upper outer arm.
26
Q

Membrane-controlled systems

A

has backing

drug reservoir

semipermeable membrean

adhesive

protective peel strip

27
Q

What a patient should be advised
about TDDSs

A

Wash your hands with soap and water before applying patch. Dry hands completely.
* Clean the area chosen with soap and water. Rinse and wipe the area completely dry with a clean tissue.
* Apply the patch at the same times of day.
* Apply to a non-hairy area of the body.
* Do not apply the patch on skin folds or wear under tight clothing.
* Do not use the same spot all the time but rotate to different areas.
* Do not apply a patch directly after showering, bathing, or swimming.
* Open the package and remove and throw away the protective backing. Do not touch the sticky side.
* Do not cut the patches.
* Attach the patch to the skin and press firmly in place for 10-15 sec. Run your finger along the outside edge of the patch to seal it.
* Remove the throw away the patch after the specified time or before applying the next patch.
* Repeat the above procedure. 55

28
Q

Ointments

A
29
Q

Gels

A
30
Q

Creams

A
31
Q

pastes

A
32
Q

plasters

A
33
Q

glycerogelatins

A
34
Q

Packaging semisolid preparations

A
35
Q

Ophthalmic dosage preparations

A
36
Q

advantages of TDD

A

Bypass hepatic “first pass”
* Bypass gastrointestinal incompatibility
* Reduce side effects
* Provide predictable and extended duration of activity
* Greater patient compliance
* Reversibility of drug delivery for removal
* Minimize inter- and intrapatient variation

Self administration
* Can use drugs with short half-life
* Administration of drugs with narrow therapeutic window
* Zero order release
* Controlled release for accurate dosing
* Control of plasma levels of potent drugs

37
Q

disadvantages of TDD

A
  • Permeation of drugs through human skin is limited
  • Stratum corneum is the rate-limiting factor
  • Only potent drugs that do not require high plasma levels are suitable for delivery
  • Skin irritation from adhesives, API, excipients and enhancers
    – Contact allergic dermatitis (involves host immunological activity)
    – Contact irritant dermatitis (direct toxic injury to cell membranes, cytoplasm or nuclei)
  • Poor adhesive of transdermal devices
38
Q

different types of TDD

parts of TDD

A

Polymeric matrix or matrices

  • Drug (Pharmaceutically Active Ingredient)
  • Permeation enhancers and other excipients
  • Adhesives